Bullish Neogen Insiders Loaded Up On US$912.8k Of Stock
Bullish Neogen Insiders Loaded Up On US$912.8k Of Stock
Usually, when one insider buys stock, it might not be a monumental event. But when multiple insiders are buying like they did in the case of Neogen Corporation (NASDAQ:NEOG), that sends out a positive message to the company's shareholders.
通常,單個內部人士買入股票可能並不是一個重要事件。 但是,當多個內部人士像紐爾真檢測(納斯達克:NEOG)一樣買入時,這會向公司的股東傳達一個積極的信息。
Although we don't think shareholders should simply follow insider transactions, logic dictates you should pay some attention to whether insiders are buying or selling shares.
雖然我們認爲股東不應該僅僅跟隨內部交易,但邏輯上你應該關注內部人士是否在買入或賣出股票。
Neogen Insider Transactions Over The Last Year
紐爾真檢測過去一年的內部交易
In the last twelve months, the biggest single purchase by an insider was when President John Adent bought US$284k worth of shares at a price of US$12.36 per share. That means that even when the share price was higher than US$11.64 (the recent price), an insider wanted to purchase shares. It's very possible they regret the purchase, but it's more likely they are bullish about the company. In our view, the price an insider pays for shares is very important. It is generally more encouraging if they paid above the current price, as it suggests they saw value, even at higher levels.
在過去的12個月裏,內部人士最大的單筆購買發生在總裁約翰·阿登以每股12.36美元的價格購買了價值28.4萬美元的股票。這意味着即使股票價格高於11.64美元(最近的價格),內部人士仍然想要購買股票。他們可能後悔購買,但更有可能的是他們對公司持看好的態度。在我們看來,內部人士爲股票支付的價格非常重要。如果他們的購買價格高於當前價格,通常會更令人鼓舞,因爲這表明他們即便在更高的水平上看到了價值。
Neogen insiders may have bought shares in the last year, but they didn't sell any. The chart below shows insider transactions (by companies and individuals) over the last year. By clicking on the graph below, you can see the precise details of each insider transaction!
紐爾真檢測的內部人士在過去一年裏可能買入了股票,但他們沒有出售。下面的圖表顯示了過去一年內部交易(由公司和個人進行)的情況。通過點擊下面的圖表,您可以查看每筆內部交易的具體細節!
Neogen is not the only stock that insiders are buying. For those who like to find small cap companies at attractive valuations, this free list of growing companies with recent insider purchasing, could be just the ticket.
紐爾真檢測不是唯一一家內部人士在買入的股票。對於那些喜歡尋找具有吸引力估值的小盤公司的投資者來說,這份包含最近內部購買的成長公司免費列表可能正合適。
Neogen Insiders Bought Stock Recently
紐爾真檢測內部人士最近購買了股票
Over the last three months, we've seen significant insider buying at Neogen. We can see that President John Adent paid US$200k for shares in the company. No-one sold. That shows some optimism about the company's future.
在過去的三個月裏,我們看到紐爾真檢測有顯著的內部買入。我們可以看到,總裁約翰·阿登爲公司的股票支付了20萬美元。沒有人出售。這顯示了對公司未來的看好。
Insider Ownership
內部持股
For a common shareholder, it is worth checking how many shares are held by company insiders. I reckon it's a good sign if insiders own a significant number of shares in the company. Insiders own 0.2% of Neogen shares, worth about US$6.2m, according to our data. We do generally prefer see higher levels of insider ownership.
對於普通股東來說,了解公司內部人士持有多少股票是值得關注的。如果內部人士在公司擁有大量股票,我認爲這是一個好兆頭。根據我們的數據,內部人士持有0.2%的紐爾真檢測股票,價值約620萬美元。我們通常更喜歡看到更高的內部持股比例。
What Might The Insider Transactions At Neogen Tell Us?
內部交易在紐爾真檢測能告訴我們什麼?
The recent insider purchase is heartening. And the longer term insider transactions also give us confidence. But we don't feel the same about the fact the company is making losses. We would certainly prefer see higher levels of insider ownership but analysis of the insider transactions suggests that Neogen insiders are expecting a bright future. Of course, the future is what matters most. So if you are interested in Neogen, you should check out this free report on analyst forecasts for the company.
最近的內部購買讓人振奮。長期的內部交易也給了我們信心。但我們對公司出現虧損的事實並不同樣感到滿意。我們當然希望看到更高的內部持股比例,但對內部交易的分析表明,紐爾真檢測的內部人士正在期待輝煌明天。當然,未來才是最重要的。所以如果你對紐爾真檢測感興趣,你應該查看這份關於分析師預測的免費報告。
But note: Neogen may not be the best stock to buy. So take a peek at this free list of interesting companies with high ROE and low debt.
但請注意:紐爾真檢測可能不是最值得買入的股票。因此請查看這份關於高ROE和低債務的有趣公司免費名單。
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions of direct interests only, but not derivative transactions or indirect interests.
在本文中,內部人士是指向相關監管機構報告其交易的個人。我們目前僅考慮公開市場交易和直接利益的私人處置,但不包括衍生交易或間接利益。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對本文有反饋?對內容有疑慮?請直接與我們聯繫。或者,發送電子郵件至 editorial-team (at) simplywallst.com。
這篇來自Simply Wall ST的文章是一般性的。我們根據歷史數據和分析師預測提供評論,採用無偏見的方法,我們的文章並不旨在提供財務建議。它不構成對任何股票的買入或賣出建議,也未考慮到您的目標或財務狀況。我們旨在爲您提供以基本數據驅動的長期分析。請注意,我們的分析可能未考慮最新的價格敏感公司公告或定性材料。Simply Wall ST在提到的任何股票中均沒有持倉。
譯文內容由第三人軟體翻譯。